Tumors of themaxillo facial region in children: retrospective analysis and long-term follow-up outcomes of 302 patients The aim of this study was to carry out a retrospective analysis of maxillo facial tumors in children and to present the lnog-term follow-upresults. Our study was performed with a retrospective analysis of 302 patients and of the age of 18 years with maxillo facial tumor treated in our clinic between 2000-2012. In addition, treatment modalities and long-term follow-up results of these patients were evaluated. According to our results, it was established that maxillo facial tumors were mostly observed in the 11-18 age group (259cases, 85.7%). There were 46 (15.2%) odontogenic, 152 (60%) odontogenic inflamatory cystics, 89 (29,4%) benign nonodontogenic and 3 (0,9%%) malignant non-odontogenic. Mixed tumors were the most common type of the odontogenic tumors, and mesenchymal tumors were the most common non-odontogenic tumors. Surgical excision, curettage or en bloc resection were adequate for treatment of these tumors.

Scopul acestui studiu a fost de a analiza structura leziunilor tumorale la copii, prezența tumorilor odontogene și neodontogene în raport cu vîrsta, sexul, caracterul biologic, spectrul histiopatologic, localizarea, cît și modalitatea de tratament. Studiul a fost efectuat ca o analiză retrospectiva a 302 pacienţi pînă la vîrsta de 18 ani cu tumori ale regiunii oro maxilo faciale in clinica noastră între anii 2000-2010. În plus, modalităţile de tratament şi evaluarea rezultatelor. Conform rezultatelor s-a stabilit că tumorile regiunii maxilo faciale au fost mai des observate în perioadele de vîrstă 11-18 ani ( 259 de cazuri, 85.7 %). 46 (15,2%) odontogene, 152 (60%) chisturi odontogene inflamatorii, 89 (29,4%) neodontogene benigne şi 3 (0,9%%) neodontogene maligne. Tumorile mixte au fost cel mai frecvent tip de tumori odontogene, iar tumorile mezenchimale au fost cele mai frecvente tumori neodontogene. Exciyia chirurgicală în bloc şi chiuretajul au fost metodele de tratament chirurgical.